This data correspond with data from other authors who have shown that GA treatment enhanced IL-1 receptor antagonist blood levels in both EAE mice and MS patients and suppressed IL-1β production by LPS-activated human monocytes in vitro [44, 45]. This evidence concerns the gene IL1B and myeloid sarcoma.